Cetuximab Falls Short as Add-on in Colon Cancer (CME/CE)
(MedPage Today) — Cetuximab plus standard chemotherapy did not fare better than chemotherapy alone in patients with stage III resected colon cancer.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com